Quick Overview: Luigi Biasco interviews Moritz Seiffert about the one-year outcomes of the randomized Amit Khera, MD, MSc, FAHA and Joanna Chikwe, MD, FAHA, chairs of the American Heart Association Committee on Scientific ... We are joined onsite by Dr John Forrest (Yale Valve Clinic, US) in this short video, who outlines the three-year outcomes of the ...

Acc 24 The Dedicate Dzhk6 - Detailed Overview & Context

Luigi Biasco interviews Moritz Seiffert about the one-year outcomes of the randomized Amit Khera, MD, MSc, FAHA and Joanna Chikwe, MD, FAHA, chairs of the American Heart Association Committee on Scientific ... We are joined onsite by Dr John Forrest (Yale Valve Clinic, US) in this short video, who outlines the three-year outcomes of the ... Drs. Kim Eagle, Dharam Kumbhani, Payal Kohli, and Ajay Kirtane debate and discuss the outcomes of the trials presented on day ... Late-breaker host Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined onsite by Michiel Voskuil (UMC Utrecht, ... Commentary by Drs. Pratik Doshi, Nare Torosyan, current Cardiology Fellow at the Keck School of Medicine of USC, and Janet ...

Photo Gallery

ACC.24: The DEDICATE-DZHK6 Trial
View from the Thoraxcenter: ACC.24 Late-breaking Science Wrap Up
TAVR vs SAVR in patients at low to intermediate risk: DEDICATE-DZHK6 one year outcomes #ACC24
ACC.24: The LIBerate-CVD Trial
ACC Cardiology Hour From ACC.24
ACC 24 Late-Breaker Discussion: The AEGIS-II Trial
ACC.24: The BE ACTIVE Trial
View from the Thoraxcenter: What's Hot at ACC.24?
ACC.24: The TACT2 Trial
Top Trials at ACC 24
ACC.24: The TACTiC Trial
WDCR 5.24.2026 AST 43.9 sec
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored